scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...9j3039S |
P356 | DOI | 10.1371/JOURNAL.PONE.0103039 |
P8608 | Fatcat ID | release_vazcep3zuzatxal2oodbu7avvu |
P932 | PMC publication ID | 4139195 |
P698 | PubMed publication ID | 25140804 |
P5875 | ResearchGate publication ID | 264937936 |
P50 | author | Bharat Singh | Q91998166 |
Rajesh Dabur | Q39800503 | ||
P2093 | author name string | Seema Singh | |
Shilpi Gupta | |||
Madhumanjiri M Gatne | |||
Sunil K Sharma | |||
Sharad Pawar | |||
Gainda L Sharma | |||
P2860 | cites work | Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Q28263689 |
Essential gene identification and drug target prioritization in Aspergillus fumigatus | Q28469156 | ||
Aspergillus fumigatus and aspergillosis | Q29617908 | ||
What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. | Q33349990 | ||
Evaluation of lysine biosynthesis as an antifungal drug target: biochemical characterization of Aspergillus fumigatus homocitrate synthase and virulence studies | Q33983108 | ||
Cross-sector review of drivers and available 3Rs approaches for acute systemic toxicity testing. | Q34000801 | ||
Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. | Q34143326 | ||
The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy | Q34290097 | ||
The virulence of the opportunistic fungal pathogen Aspergillus fumigatus requires cooperation between the endoplasmic reticulum-associated degradation pathway (ERAD) and the unfolded protein response (UPR). | Q34775365 | ||
Standardization of an experimental murine model of invasive pulmonary aspergillosis | Q35091545 | ||
Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations | Q35091593 | ||
Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. | Q35138591 | ||
Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. | Q35537748 | ||
Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA. | Q51963462 | ||
Oral acute toxic class method: a successful alternative to the oral LD50 test. | Q52938613 | ||
Antifungal Activity of Amphotericin B Conjugated to Carbon Nanotubes | Q57275267 | ||
Synthesis and anti-angiogenesis activity of coumarin derivatives | Q79772894 | ||
Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
Antifungal activity of some coumarins obtained from species of Pterocaulon (Asteraceae) | Q83016437 | ||
Proteomic characterization of Aspergillus fumigatus treated with an antifungal coumarin for identification of novel target molecules of key pathways | Q83990864 | ||
Anti-inflammatory and antioxidant activity of coumarins designed as potential fluorescent zinc sensors | Q94538884 | ||
Synthetic and natural coumarins as cytotoxic agents | Q36048289 | ||
The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection model | Q36313729 | ||
What is the current and future status of conventional amphotericin B? | Q36481251 | ||
In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. | Q36558376 | ||
Update on echinocandin antifungals | Q37118866 | ||
The innate immune response to Aspergillus fumigatus | Q37554943 | ||
New lead structures in antifungal drug discovery | Q37823634 | ||
Immunotherapy of aspergillosis | Q37949009 | ||
Invasive aspergillosis: resistance to antifungal drugs | Q37983464 | ||
Invasive aspergillosis: new insights into disease, diagnostic and treatment | Q38070749 | ||
Azole resistant Aspergillus fumigatus: an emerging problem. | Q38096696 | ||
Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene | Q38283306 | ||
A pulmonary aspergillosis case with fatal course in a patient with SIRS clinic. | Q39047135 | ||
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group | Q40612309 | ||
Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis | Q42675899 | ||
Efficacy of caspofungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methods | Q42708837 | ||
Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin | Q44583938 | ||
MR features of cerebral aspergillosis in an immunocompetent patient: correlation with histology and elemental analysis | Q44772415 | ||
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation. | Q46034499 | ||
A GHS-consistent approach to health hazard classification of petroleum substances, a class of UVCB substances | Q46187449 | ||
Antifungal activity of coumarins | Q46666215 | ||
Antitubercular activity of new coumarins. | Q50279898 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | aspergillosis | Q259626 |
murine model | Q122890741 | ||
P304 | page(s) | e103039 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | In vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosis | |
P478 | volume | 9 |
Q52583562 | Animal Models of Aspergillosis. |
Q60920669 | Antifungal Activity of Coumarin Against Is Related to Apoptosis |
Q49900248 | Antimicrobial Efficacy of Synthetic Pyranochromenones and (Coumarinyloxy)acetamides. |
Q48290416 | Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues. |
Q33689767 | Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization. |
Search more.